Flavored nicotine tablets, the tobacco industry’s latest product, worry public health advocates

by | Nov 17, 2026 | Health

Flavored nicotine tablets, the tobacco industry’s latest product, worry public health advocates

Major tobacco companies have begun rolling out flavored nicotine tablets as the latest addition to their portfolio of alternative nicotine products. Philip Morris International introduced Zyn Melts in the United Kingdom and Switzerland, while Japan Tobacco International launched Perlz in the U.K. in May. In the United States, Nic Nac Naturals has been selling flavored lozenges since 2022, with distribution reaching approximately 3,000 stores nationwide. These tablets function similarly to nicotine pouches but dissolve without leaving a wet sachet to discard, making them more convenient for users who tuck them against their gums.

Public health experts have raised significant concerns about the new products’ potential appeal to minors. The tablets’ resemblance to common mints or lozenges may make them appear harmless to children and adolescents, according to Magnus Lundbäck, a cardiologist and nicotine researcher at the Karolinska Institutet in Stockholm. The tablets are available in various milligram doses, with Zyn Melts and Perlz offered in 1 and 2 milligram doses, while Nic Nac lozenges come in 3 and 6 mg doses. Industry officials contend they are marketing these products exclusively to adults and emphasize child-resistant packaging, but concerns persist about unintended youth exposure.

The emergence of nicotine tablets reflects broader trends in the alternative nicotine market. Nicotine pouch sales reached $9.2 billion globally in 2025, with annual sales growth of 50% over the past five years. Poison control centers in the United States reported that calls involving nicotine poisoning nearly doubled from 2024 to 2025, with three-quarters of cases last year involving children under age 6. Public health advocates question whether these products genuinely help smokers transition away from cigarettes or instead expand nicotine consumption overall. Regulators face an ongoing challenge balancing potential benefits for adult smokers seeking less harmful alternatives against risks of youth addiction and accidental poisoning.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI